D J Hellerstein

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi Venlafaxine in the treatment of dysthymia: an open-label study
    D J Hellerstein
    Department of Psychiatry, Beth Israel Medical Center, New York, NY, USA
    J Clin Psychiatry 60:845-9. 1999
  2. ncbi Longitudinal comparison of depressive personality disorder and dysthymic disorder
    John C Markowitz
    New York State Psychiatric Institute and Columbia University, New York, NY 10032, USA
    Compr Psychiatry 46:239-45. 2005
  3. ncbi Does personality disorder decrease the likelihood of remission in early-onset chronic depression?
    Vito Agosti
    Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA
    Compr Psychiatry 50:491-5. 2009
  4. ncbi Escitalopram versus placebo in the treatment of dysthymic disorder
    David J Hellerstein
    St Luke s Roosevelt Hospital Center, New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York 10032, USA
    Int Clin Psychopharmacol 25:143-8. 2010
  5. ncbi The impact of comorbid dysthymic disorder on outcome in personality disorders
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY 10032, USA
    Compr Psychiatry 51:449-57. 2010
  6. ncbi Impairment in psychosocial functioning associated with dysthymic disorder in the NESARC study
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY, USA
    J Affect Disord 127:84-8. 2010
  7. ncbi Assessing behavioral coping preferences of psychiatric inpatients: a pilot study
    David J Hellerstein
    Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, NY, USA
    Medscape J Med 10:271. 2008
  8. ncbi Aripiprazole as an adjunctive treatment for refractory unipolar depression
    David J Hellerstein
    St Luke s Roosevelt Hospital Center, United States
    Prog Neuropsychopharmacol Biol Psychiatry 32:744-50. 2008
  9. ncbi Decreasing the use of restraint and seclusion among psychiatric inpatients
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY, USA
    J Psychiatr Pract 13:308-17. 2007
  10. ncbi Assessing obesity and other related health problems of mentally ill Hispanic patients in an urban outpatient setting
    David J Hellerstein
    New York State Psychiatric Institute, Harkness Pavilion, 180 Fort Washington Ave, New York, NY 10032, USA
    Psychiatr Q 78:171-81. 2007

Detail Information

Publications21

  1. ncbi Venlafaxine in the treatment of dysthymia: an open-label study
    D J Hellerstein
    Department of Psychiatry, Beth Israel Medical Center, New York, NY, USA
    J Clin Psychiatry 60:845-9. 1999
    ..The purpose of this open-label study was to provide preliminary data on the tolerability and effectiveness of venlafaxine for patients with dysthymia...
  2. ncbi Longitudinal comparison of depressive personality disorder and dysthymic disorder
    John C Markowitz
    New York State Psychiatric Institute and Columbia University, New York, NY 10032, USA
    Compr Psychiatry 46:239-45. 2005
    ..The authors attempted to replicate findings of Klein and Shih in longitudinally followed patients with personality disorder or major depressive disorder (MDD) in the Collaborative Longitudinal Personality Disorders Study...
  3. ncbi Does personality disorder decrease the likelihood of remission in early-onset chronic depression?
    Vito Agosti
    Department of Psychiatry, New York State Psychiatric Institute, New York, NY 10032, USA
    Compr Psychiatry 50:491-5. 2009
    ..Elevated rates of PD have been noted in early-onset and chronic forms subtypes of depression. However, scant data exist regarding the link between PD and outcome for this depression subtype...
  4. ncbi Escitalopram versus placebo in the treatment of dysthymic disorder
    David J Hellerstein
    St Luke s Roosevelt Hospital Center, New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, New York 10032, USA
    Int Clin Psychopharmacol 25:143-8. 2010
    ..A larger study sample or higher escitalopram dose may show more significant placebo-medication differences...
  5. ncbi The impact of comorbid dysthymic disorder on outcome in personality disorders
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY 10032, USA
    Compr Psychiatry 51:449-57. 2010
    ..The goal of our study was to investigate the impact of dysthymic disorder (DD), a form of chronic depression, on naturalistic outcome in individuals with personality disorders (PDs)...
  6. ncbi Impairment in psychosocial functioning associated with dysthymic disorder in the NESARC study
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY, USA
    J Affect Disord 127:84-8. 2010
    ..We hypothesized that individuals with chronic low-grade depression, dysthymic disorder, would have more impaired functioning than individuals with acute major depression or the general population...
  7. ncbi Assessing behavioral coping preferences of psychiatric inpatients: a pilot study
    David J Hellerstein
    Columbia University College of Physicians and Surgeons, New York State Psychiatric Institute, New York, NY, USA
    Medscape J Med 10:271. 2008
    ..Individual crisis management strategies may be one way to reduce restraint and seclusion, which may include active engagement of inpatients in behavioral coping plans...
  8. ncbi Aripiprazole as an adjunctive treatment for refractory unipolar depression
    David J Hellerstein
    St Luke s Roosevelt Hospital Center, United States
    Prog Neuropsychopharmacol Biol Psychiatry 32:744-50. 2008
    ..Aripiprazole may be an effective adjunctive treatment in outpatients with unipolar depression that has been refractory to treatment with SSRI or SNRI medication...
  9. ncbi Decreasing the use of restraint and seclusion among psychiatric inpatients
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY, USA
    J Psychiatr Pract 13:308-17. 2007
    ..Our hypotheses were that interventions could reduce the number of patients as well as patient hours in restraint and seclusion, without an increase in adverse outcomes (fights/assaults, staff injuries, and elopements)...
  10. ncbi Assessing obesity and other related health problems of mentally ill Hispanic patients in an urban outpatient setting
    David J Hellerstein
    New York State Psychiatric Institute, Harkness Pavilion, 180 Fort Washington Ave, New York, NY 10032, USA
    Psychiatr Q 78:171-81. 2007
    ....
  11. ncbi Integrating services for schizophrenia and substance abuse
    D J Hellerstein
    New York State Psychiatric Institute, Department of Psychiatry, Beth Israel Medical Center, New York, New York, USA
    Psychiatr Q 72:291-306. 2001
    ..referral to specialized programs, and the importance of initial engagement and ongoing reengagement in successful treatment...
  12. ncbi Bupropion sustained-release for the treatment of dysthymic disorder: an open-label study
    D J Hellerstein
    Department of Psychiatry, Beth Israel Medical Center, New York New York, USA
    J Clin Psychopharmacol 21:325-9. 2001
    ..Double-blind prospective studies are needed for the comparison of bupropion SR to both placebo and other medications, assessing both initial and sustained responses to treatment...
  13. ncbi Citalopram in the treatment of dysthymic disorder
    David J Hellerstein
    New York State Psychiatric Institute, New York, New York 10032, USA
    Int Clin Psychopharmacol 19:143-8. 2004
    ..Double-blind prospective studies are needed comparing citalopram both to placebo and to other medications, assessing both initial and sustained response to treatment...
  14. ncbi Rating dysthymia: an assessment of the construct and content validity of the Cornell Dysthymia Rating Scale
    David J Hellerstein
    New York State Psychiatric Institute, New York, NY 10032, USA
    J Affect Disord 71:85-96. 2002
    ..The purpose of this study was to compare these instruments in an outpatient sample of dysthymic patients...
  15. ncbi Adding group psychotherapy to medication treatment in dysthymia: a randomized prospective pilot study
    D J Hellerstein
    Department of Psychiatry, Beth Israel Medical Center, New York, USA
    J Psychother Pract Res 10:93-103. 2001
    ..Results provide preliminary evidence that group therapy may provide additional benefit to medication-responding dysthymic patients, particularly in interpersonal and psychosocial functioning...
  16. ncbi Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality
    D J Hellerstein
    Outpatient Mental Health Services, Beth Israel Medical Center, New York, NY 10003, USA
    Am J Psychiatry 157:1436-44. 2000
    ....
  17. ncbi Divergent fates of the medical humanities in psychiatry and internal medicine: should psychiatry be rehumanized?
    Bret R Rutherford
    Department of Psychiatry, NY State Psychiatric Institute, New York, NY 10032, USA
    Acad Psychiatry 32:206-13. 2008
    ....
  18. ncbi Predicting falls among psychiatric inpatients: a case-control study at a state psychiatric facility
    Irene Estrin
    Department of Psychiatry, New York State Psychiatric Institute, 1051 Riverside Dr, New York, NY 10032, USA
    Psychiatr Serv 60:1245-50. 2009
    ..The purpose of the study was to add to the research on risk of falling in an understudied population of psychiatric inpatients in an acute setting...
  19. ncbi The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication
    Alan J Gelenberg
    University of Arizona Health Sciences Center, Tucson, AZ 85724, USA
    J Clin Psychiatry 65:1114-9. 2004
    ..A continuation study of an extract of St. John's wort (Hypericum perforatum) for depression was performed in follow-up to an acute study that found no significant difference between St. John's wort extract and placebo...
  20. ncbi Aripiprazole as an adjunctive treatment for refractory major depression
    David J Hellerstein
    Prog Neuropsychopharmacol Biol Psychiatry 28:1347-8. 2004
  21. ncbi Developing supportive psychotherapy as evidence-based treatment
    David J Hellerstein
    Am J Psychiatry 165:1355-6; author reply 1356. 2008